** Shares of Australia's Control Bionics CBL.AX rise as much as 4.8% to A$0.044, its highest level since February 17
** The medical device manufacturer raises A$2.0 million ($1.27 million) via private placement at an issue price of A$0.045 per share
** Issue price represents a premium of 7.1% to stock's last closing
** Funds raised to help the company "focus on revenue growth in its core operations and the expansion into new high-potential markets" — CBL
** Stock has fallen 26.7% this year, as of 0118 GMT
($1 = 1.5778 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.